Overview
- 48 inspections across 43 sites are on record.
- 148 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2014-11-13.
At a glance
Inspections
48
Sites
43
Observations
148
Career since
May 2010
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Diversified Pharmacy Inc dba University Compounding Pharmacy | 13 Nov 2014 | Human Drugs | View 483 → |
| L. Perrigo Company | 4 Sep 2014 | Human Drugs | View 483 → |
| Fertin Pharma A/s | 20 Jun 2014 | Human Drugs | |
| Ricola Ag | 13 Jun 2014 | Human Drugs | View 483 → |
| BASF Grenzach GmbH | 6 Jun 2014 | Human Drugs | On file |
Sites inspected
Diversified Pharmacy Inc dba University Compounding PharmacyTroy, United States1 insp.
L. Perrigo CompanyAllegan, United States1 insp.
Fertin Pharma A/sVejle, Denmark1 insp.
Ricola AgLaufen, Switzerland1 insp.
BASF Grenzach GmbHGrenzach-Wyhlen, Germany1 insp.
Co-investigators
Investigators who share inspections with this person.
Sarah M Meng8 shared
Emily J Orban7 shared
Rebecca E Dombrowski6 shared
Patsy J Domingo6 shared
Jeffrey D Meng4 shared
Thomas A Peter4 shared
Sanket N Patel3 shared
Constantin Y Philopoulos2 shared
Lisa M Thursam2 shared
Tracey L Siebesma2 shared
Full investigator report
Get the verbatim findings behind Sarah M Napier's 148 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site